Licensed cannabis producer MediPharm Labs Inc(TSX: V.LABS , Forum) on Friday announced that pharmaceutical industry veteran David Mayers has been brought on as the Company’s Chief Operating Officer, while top cannabis compliance professional Anuja Siwakoti has been appointed as the Company’s Director of Global Regulatory and Scientific Affairs.
For more on this news, click here.
Last week, MediPharm entered into a Cannabis Concentrate Program Agreement with Emerald Health Therapeutics Inc. (TSXV: EMH) where LABS will receive dried cannabis to create premium quality cannabis oil over a three-year term.
FULL DISCLOSURE: MediPharm Labs Inc. is a paid client of Stockhouse Publishing.